https://www.selleckchem.com/pr....oducts/AR-42-HDAC-42
1% 3 severe (red) in 2 patients (2.2%). The most frequent drugs involved in PPI were benzodiazepines (30%). Cobicistat was the drug most frequently involved in potential interactions (42.2%). The prevalence of PPI among older HIV-infected persons gives cause for concern, as it is almost 90%. Optimization strategies, including a critical review of the treatment plan, should be implemented in clinical routine by a multidisciplinary team, in particular in patients with multiple comorbidities and polypharmacy. The STOPP/START crit
Like
Comment
Share
